T Cell Lymphomas
Feature
Third-generation Black woman physician makes cancer research history
African American surgeon helped found ASCO and collaborated with her father to achieve lasting breakthroughs in chemotherapy.
Feature
Ex–hospital porter a neglected giant of cancer research
An Indian immigrant who once emptied bedpans in a Boston hospital went on to become the “father of chemotherapy.”
Feature
DKMS: Small nonprofit to world’s largest stem cell donor registry
A German family’s tragedy launched DKMS, a multinational organization whose goal is to “delete blood cancer.”
Latest News
Pfizer offers refund if drug ‘doesn’t work’
Although Pfizer claims that its pilot program is a first in the industry, there have been others that are similar.
Conference Coverage
Blacks and Hispanics have higher inpatient use for mycosis fungoides
Findings reinforce need to maintain “higher index of suspicion” in these patients.
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
Conference Coverage
Why a mycosis fungoides diagnosis takes so long
“Judicious use of molecular studies may help in establishing the diagnosis, but I don’t think any one molecular study is ever going to be our home...
Conference Coverage
Phase 1 study shows feasibility, safety, efficacy of STAR T cells for ALL
Conference Coverage
Duvelisib response rate encouraging in phase 2 PRIMO trial of patients with r/r PTCL
Conference Coverage
Allogeneic transplant leads to durable remissions in T-cell lymphomas
Retrospective study demonstrates overall survival over 50% at 5 years, though transplant-related mortality and graft-versus-host disease need to...
From the Journals
Pigment traits, sun sensitivity associated with risk of non-Hodgkin lymphomas and chronic lymphocytic leukemia
The presence of “many or very many nevi [moles]” was particularly associated with the risk of CLL.